These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 31837567)

  • 1. Critical studies of harm reduction: Overdose response in uncertain political times.
    Watson TM; Kolla G; van der Meulen E; Dodd Z
    Int J Drug Policy; 2020 Feb; 76():102615. PubMed ID: 31837567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Everybody is impacted. Everybody's hurting": Grief, loss and the emotional impacts of overdose on harm reduction workers.
    Kolla G; Khorasheh T; Dodd Z; Greig S; Altenberg J; Perreault Y; Bayoumi AM; Kenny KS
    Int J Drug Policy; 2024 May; 127():104419. PubMed ID: 38599035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual overdose monitoring services/mobile overdose response services: estimated number of potentially averted drug poisoning fatality events by various telephone and digital-based overdose prevention/harm reduction services in North America.
    Rioux W; Enns B; Ghosh SM
    Front Public Health; 2023; 11():1242795. PubMed ID: 37927877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing Use of Supervised Consumption Services among Street-involved Youth and Young Adults in the Context of an Overdose Crisis.
    Lee-Pii K; DeBeck K; Choi J; Sedgemore KO; Kerr T; Kennedy MC
    J Urban Health; 2024 Apr; 101(2):233-244. PubMed ID: 38536600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.
    Bardwell G; Austin T; Maher L; Boyd J
    Harm Reduct J; 2021 Mar; 18(1):29. PubMed ID: 33678163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
    Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
    Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.
    Lu A; Kim C; Rosen JG; Thompson E; Tardif J; Welwean R; Park JN
    Subst Use Misuse; 2024; 59(4):520-526. PubMed ID: 38044494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study.
    Ali F; Russell C; Kaura A; Leslie P; Bayoumi AM; Hopkins S; Wells S
    PLoS One; 2023; 18(10):e0292862. PubMed ID: 37844109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic.
    Galarneau LR; Speed K; Taylor M; Hyshka E
    Can J Public Health; 2023 Oct; 114(5):787-795. PubMed ID: 37462841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing Canada's first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS).
    Rioux W; Taplay P; Morris-Miller L; Ghosh SM
    Harm Reduct J; 2024 May; 21(1):102. PubMed ID: 38807227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using alone at home: What's missing in housing-based responses to the overdose crisis?
    Fleming T; Boyd J; Chayama KL; Knight KR; McNeil R
    Harm Reduct J; 2024 Jan; 21(1):24. PubMed ID: 38281992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
    Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
    J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California.
    Wenger LD; Morris T; Knight KR; Megerian CE; Davidson PJ; Suen LW; Majano V; Lambdin BH; Kral AH
    Int J Drug Policy; 2024 Apr; 126():104366. PubMed ID: 38492432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of Canadian Healthcare and Harm Reduction Workers on Mobile Overdose Response Services: A Qualitative Study.
    Sedaghat N; Seo B; Rider N; Rioux W; Ghosh SM
    Subst Use Addctn J; 2024 Jul; 45(3):506-514. PubMed ID: 38525593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical narrative inquiry to understand the impacts of an overdose prevention site on the lives of site users.
    Oudshoorn A; Sangster Bouck M; McCann M; Zendo S; Berman H; Banninga J; Le Ber MJ; Zendo Z
    Harm Reduct J; 2021 Jan; 18(1):6. PubMed ID: 33407553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender and the overdose crisis in North America: Moving past gender-neutral approaches in the public health response.
    Collins AB; Bardwell G; McNeil R; Boyd J
    Int J Drug Policy; 2019 Jul; 69():43-45. PubMed ID: 31078907
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a digital platform to improve community response to overdose and prevention among harm reduction organizations.
    Claborn K; Creech S; Conway FN; Clinton NM; Brinkley KT; Lippard E; Ramos T; Samora J; Miri A; Benzer J
    Harm Reduct J; 2022 Jun; 19(1):62. PubMed ID: 35658871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the barriers and facilitators to implementing and sustaining Mobile Overdose Response Services from the perspective of Canadian key interest groups: a qualitative study.
    Seo B; Rider N; Rioux W; Teare A; Jones S; Taplay P; Monty Ghosh S
    Harm Reduct J; 2024 Feb; 21(1):28. PubMed ID: 38308262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.